• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us
    • Careers

Cardio3 BioSciences to host Investop & Analyst day in New York on Friday, January 30, 2015

January 13, 2015 By Celyad

Company Management and Scientific Experts in Cardiac Cell Therapy and Immuno-Oncology to Discuss Science and Portfolio Drug Candidates

Mont-Saint-Guibert, Belgium – Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of cell therapies, will host an Investor & Analyst Day on Friday 30th January 2015 in New York City.

The event will bring together scientific experts and key opinion leaders in cardiology and immunooncology from the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine (MD, USA), the Institute of Cancer Sciences, University of Manchester (UK), the Mayo Clinic (MN, USA), Dartmouth College (NH, USA) and the Dana-Farber Cancer Institute (MA, USA). Together with members of Cardio3 BioSciences’ management team, they will provide a comprehensive overview of the company’s current pipeline in cardiac cell therapy, cardiac medical devices and immunooncology, substantiated with pre-clinical and clinical data

The objective of this event is to present the Company’s current pipeline of products, development perspectives for the coming years, and near and long-term business strategy. This event will also enable members of the financial community to meet with Cardio3 BioSciences’ management and key opinion leaders for in-depth discussion and understanding of the Company and its strategy.

Details of the Investor & Analyst Day:

  • Date: Friday January 30, 2015
  • Time: 7:30 AM – 12:15 PM ET
  • Location: The New York Palace, 455 Madison Avenue, New York

Attendance at The Cardio3 BioSciences Analyst Day is by invitation only.

To request an invitation for the event, please contact Courtney Dugan or Taylor Donovan of The Ruth Group at cdugan@theruthgroup.com / tdonovan@theruthgroup.com or +1 646-536-7024 / 7017. 

Download press release(s)
Communiqué de presse
Press Release

Filed Under: Corporate, Regulated

Footer

  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use

Our website uses cookies including analytics cookies to help improve it by collecting statistics on how visitors use our website. By clicking on "I accept", you allow us to place these analytics cookies. We also use cookies that are necessary for the good functioning of our website. You can find out more information about the cookies we use by visiting our Cookie Policy. I acceptI refuseCookie Policy